363 related articles for article (PubMed ID: 30133717)
1. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
2. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients.
Abdel-Al A; El-Ahwany E; Zoheiry M; Hassan M; Ouf A; Abu-Taleb H; Abdel Rahim A; El-Talkawy MD; Zada S
Virus Res; 2018 Jul; 253():135-139. PubMed ID: 29932949
[TBL] [Abstract][Full Text] [Related]
3. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
Liu B; Xiang Y; Zhang HS
Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer.
Motawi TM; Sadik NA; Shaker OG; Ghaleb MH
Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
8. Serum MicroRNAs as predictors for fibrosis progression and response to direct-acting antivirals treatment in hepatitis C virus genotype-4 Egyptian patients.
Khairy RMM; Hmmad SS; Sayed M; Ahmed HA; Esmail MAM
Int J Clin Pract; 2021 Apr; 75(4):e13954. PubMed ID: 33345414
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
Shaker OG; Senousy MA
J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
12. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
13. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-625 as an Emerging Biomarker for Liver Cirrhosis.
Ghaempoor M; Arefian E; Mohebbi SR; Shanaki M; Kazerouni F; Hatami B
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969085
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
17. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients.
Demerdash HM; Hussien HM; Hassouna E; Arida EA
Biomed Res Int; 2017; 2017():1806069. PubMed ID: 28642869
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
Gui J; Tian Y; Wen X; Zhang W; Zhang P; Gao J; Run W; Tian L; Jia X; Gao Y
Clin Sci (Lond); 2011 Mar; 120(5):183-93. PubMed ID: 20815808
[TBL] [Abstract][Full Text] [Related]
19. Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.
Bao S; Zheng J; Li N; Huang C; Chen M; Cheng Q; Yu K; Chen S; Zhu M; Shi G
Gut Liver; 2017 Nov; 11(6):860-869. PubMed ID: 28750488
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
